Study on cow ghee versus soybean oil on 7,12-dimethylbenz(a)-anthracene induced mammary carcinogenesis & expression of cyclooxygenase-2 & peroxisome proliferators activated receptor- γ in rats

Indian Journal of Medical Research

Volumn 133, Issue 5, 2011, Pages 497-503

  Rani, Rita ^a   Kansal, Vinod K ^a  

^a NATIONAL DAIRY RESEARCH INSTITUTE   (India)

Author keywords

Cow ghee; Cyclooxygenase 2; DMBA; Mammary carcinogenesis; PPAR ; Soybean oil

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; COW GHEE; CYCLOOXYGENASE 2; MILK FAT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SOYBEAN OIL; UNCLASSIFIED DRUG; 7,12 DIHYDROXYMETHYLBENZ(A)ANTHRACENE; 7,12-DIHYDROXYMETHYLBENZ(A)ANTHRACENE; BENZ[A]ANTHRACENE DERIVATIVE; PRIMER DNA;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CARCINOGENESIS; CONTROLLED STUDY; FAT INTAKE; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; MAMMARY GLAND; NONHUMAN; RAT; ANALYSIS OF VARIANCE; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; ANIMALS; BENZ(A)ANTHRACENES; CYCLOOXYGENASE 2; DIETARY FATS; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY NEOPLASMS, EXPERIMENTAL; PPAR GAMMA; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOYBEAN OIL;

EID: 79958031511     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of world wide burden of cancer in 2008: Globocan 2008. Int J Cancer 2010; 127: 2893-917.
2. Wynder EL, Rose DP, Cohen LA. Diet and breast cancer in 2. causation and therapy. Cancer 1986; 58: 1804-13.
3. Yanagi S, Yamashita M, Sakamoto M, Kumazawa K, Imai S. Comparative effects of butter, margarine, safflower oil and dextrin on mammary tumorigenesis in mice and rats. In: Kabara JJ, editor. The pharmacological effects of lipids III: The role of lipids in cancer research. Galena, IL: Lauricidin Inc.; 1989. p.159-69.
4. Welsch CW. Relationship between dietary fat and experimental mammary tumorigenesis: a review and critique. Cancer Res 1992;52 (Suppl 7):2040S-8S.
5. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, et al. Cyclooxygenase in biology and disease. FASEB J 1998;12:1063-73.
6. Liu CH, Chang SH, Narko K, Trifan OC, Wu MT, Smith E, et al. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 2001; 276: 18563-9.
7. Krey G, Braissant O, L'Horset F, Kalkhoven E, Perroud M, Parker MG, et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 1997; 11: 779-91.
8. Elstner E, Muller C, Koshizuka K, Williamson EA, Park D, Asou H, et al. Ligands for peroxisome proliferator activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BAX mice. Proc Natl Acad Sci USA 1998; 95: 8806-11.
9. Suh N, Wang Y, Williams CR, Risingsong R, Gilmer T, Willson TM, et al. A new ligand for the peroxisome proliferators-activated receptor-γ (PPAR-γ), GW7845, inhibits rat mammary carcinogenesis. Cancer Res 1999; 59: 5671-3.
10. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993; 123: 1939-51.
11. Harris RE, Robertson FM, Abou-Issa HM, Farrar WB, Brueggemeier R. Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer. Med Hypotheses l999;52: 291-2.
12. Shou M, Korzekwa KR, Krausz KW, Buters JT, Grogan J, Goldfarb I, et al. Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz(a)anthracene. Mol Carcinogen 1996; 17: 241-9.
13. Nakatsugi S, Ohta T, Kawamori T, Mutoh M, Tanigawa T, Watanabe K, et al. Chemoprevention by nimesulide, a selective cyclo-oxygenase-2 inhibitor of 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP)-induced mammary gland carcinogenesis in rats. Jpn J Cancer Res 2000; 91: 886-92.
14. Harris RE, Alshafie GA, Abou-Issa H. Seibert K. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase-2 inhibitor. Cancer Res 2000; 60: 2101-3.
15. Subbaramaiah K, Norton L, Gerald W, Dannenberg AJ. Cyclooxygenase-2 is overexpressed in HER2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3. J Biol Chem 2002; 277: 18649-57.
16. Gimble JM, Pighetti GM, Lerner MR, Wu X, Lightfoot SA, Brackett DJ, et al. Expression of peroxisome proliferator activated receptor mRNA in normal and tumorigenic rodent mammary glands. Biochem Biophys Res Commun 1998; 253: 813-7.
17. Yee LD, Guo Y, Bradbury J, Suster S, Clinton SK, Seewaldt VL. The antiproliferative effects of PPAR-γ ligands in normal human mammary epithelial cells. Breast Cancer Res Treat 2003; 78: 179-92.
18. Toyoda M, Takagi H, Horiguchi N, Kakizaki S, Sato K, Takayama H, et al. A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells. Gut 2002; 50: 563-7.
19. Chen GG, Lee JF, Wang SH, Chan UP, Ip PC, Lau WY. Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and NF-kappaB in human colon cancer. Life Sci 2002; 70: 2631-46.
20. Konstantinopoulos PA, Vandoros GP, Sotiropoulou-Bonikou G, Kominea A, Papavassiliou AG. NF-κB/PPARγ and/or AP-1/PPARγ 'on/off' switches and induction of CBP in colon adenocarcinomas: correlation with COX-2 expression. Int J Colorectal Dis 2007; 22: 57-68.
21. Badawi AF, Badr MZ. Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-.γ. Int J Oncol 2002; 20: 1109-22.
22. Badawi AF, Badr MZ. Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-γ and levels of prostaglandin E2 and 15-deoxy-Δ12,14 -prostaglandin J2 in human breast cancer and metastasis. Int J Cancer 2003; 103: 84-90.
23. Yang WL, Frucht H. Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells. Carcinogenesis 2001; 22: 1379-83.
24. Clay CE, Namen AM, Atsumi G, Willingham MC, High KP, Kute TE, et al. Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells. Carcinogenesis 1999; 20: 1905-11.
25. Badawi AF, EL-Sohemy A, Stephen LL, Ghoshal AK, Archer MC. The effect of dietary n-3 and n-6 polyunsaturated fatty acids on the expression of cyclooxygenase1 and 2 and level of p21ras in rat mammary glands. Carcinogenesis 1998; 19: 905-10.
26. Ip C, Banni S, Angioni E, Carta G, McGinley J, Thompson HJ, et al. Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. J Nutr 1999; 129: 2135-42.
27. Cheng WL, Lii CK, Chen HW, Lin TH, Liu KL. Contribution of conjugated linoleic acid to the suppression of inflammatory responses through the regulation of the NF-kappaB pathway. J Agric Food Chem 2004; 52: 71-8.
28. Degner SC, Kemp MQ, Bowden GT, Romagnolo DF. Conjugated linoleic acid attenuates cyclooxygenase-2 transcriptional activity via an anti-AP-1 mechanism in MCF-7 breast cancer cells. J Nutr 2006; 136: 421-7.
29. McCarty MF. Activation of PPAR gamma may mediate a portion of the anticancer activity of conjugated linoleic acid. Med Hypotheses 2000; 55: 187-8.
30. Bozzo F, Bocca C, Colombatto S, Miglietta A. Antiproliferative effect of conjugated linoleic acid in caco-2 cells: involvement of PPAR gamma and APC/beta-catenin pathways. Chem Biol Interact 2007; 169: 110-21.
31. Yasui Y, Hosokawa M, Sahara T, Suzuki R, Ohgiya S, Kohno H, et al. Bitter gourd seed fatty acid rich in 9c,11t,13t-conjugated linolenic acid induces apoptosis and up-regulates the GADD45, p53 and PPARgamma in human colon cancer Caco-2 cells. Prostaglandins Leukot Essent Fatty Acids 2005; 73: 113-9.